FDAnews
www.fdanews.com/articles/72612-uk-drug-discovery-company-oxagen-completes-59-8-million-financing

UK Drug Discovery Company Oxagen Completes $59.8 Million Financing

May 23, 2005

Oxagen Ltd, a drug discovery and development company specializing in inflammation, announced Monday the successful completion of a $59.8 Million (GBP31.6 Million) Series B round led by MPM Capital. The proceeds of the funding will be used to advance Oxagen's lead programme, a novel small molecule anti-inflammatory for asthma to the clinic and to expand the company's clinical and preclinical stage portfolio.

iWon (http://money.iwon.com/jsp/nw/nwdt_rt.jsp?cat=USMARKET&src=704&feed=dji§ion=news&news_id=dji-00005620050523&date=20050523&alias=/alias/money/cm/nw)